Skip to main
ABSI

Absci Corp (ABSI) Stock Forecast & Price Target

Absci Corp (ABSI) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Absci is well-positioned for success due to its innovative platform that integrates generative AI and high-throughput biology to design novel protein therapeutics. With a lead product candidate, ABS-201, in phase 1/2a for Pattern Hair Loss and promising results in non-human clinical trials, Absci has potential for strong sales growth in the PHL and endometriosis markets. However, competition in these markets and reliance on third-party suppliers for manufacturing are potential risks that could impact the company's success.

Bears say

Absci is a promising but risky investment opportunity, as its leading drug candidate ABS-201 shows potential in treating endometriosis and alopecia through its unique discovery approach and promising clinical results, but the company is still in the development stage and the cause of endometriosis is not fully understood.

Absci Corp (ABSI) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Absci Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Absci Corp (ABSI) Forecast

Analysts have given Absci Corp (ABSI) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Absci Corp (ABSI) has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Absci Corp (ABSI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.